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Background
In the absence of treatment, 50% of HIV-infected chil-
dren will die before 2 years of age. In a recent rando-
mized controlled trial, a 76% decrease in mortality was
observed in infants receiving early combination antire-
troviral therapy [1]. The World Health Organization
now recommends starting all HIV-infected infants on
combination antiretroviral therapy on diagnosis [2].
However, few data are available outside a well-controlled
research setting.
Purpose of the study
To show the feasibility and effectiveness of treating
HIV-infected infants in a state-funded clinic located in a
poorly resourced South African township.
Methods
A retrospective chart review was performed of all HIV-1
infected infants initiated on combination antiretroviral
therapy (cART) between 1st May 2005 and 31st May
2008 at the Edendale Family Clinic, Pietermaritzburg,
South Africa. All HIV-1 infected infants who were less
than 1 year of age when antiretroviral therapy was
initiated, and who had completed at least 6 months of
treatment, were included. Weight for age Z scores, CD4
%, viral loads (VL) and haemoglobin were collected on
initiation of treatment and at 6-monthly intervals there-
after. Virological success was defined as VL<25 copies/
ml, immune recovery as CD4>25%. Z scores were ana-
lyzed using Epi-Info.
Summary of results
Of 129 treated infants, 94 completed 6 months of cART;
60 completed 12 months and 39 completed 18 months
of treatment. Mean age at initiation was 8 months
(range 2.1-11.7). 77.2% had advanced disease (WHO
Stage 3 or 4). The infants were severely malnourished,
w i t ham e a nZ - s c o r eo f- 2 . 4( r a n g e- 6 . 1-+ 0 . 8 ) .M e a n
baseline VL was 4700 000 copies/ml. After 6 months of
treatment, 52.3% of babies had an undetectable VL, with
75% having a VL of < 400 copies/ml. Viral suppression
was achieved in 34 (56.9%) out of the 60 infants who
completed 1 year of cART and 79.3% had a VL <400
copies/ml. Undetectable VL was found in 78.8% of the
39 children who received 18 months of treatment.
Weight for age Z score increased from a mean of -2.4
(<3rd centile) at initiation of treatment to -0.3 (38th
centile) for the children who received 18 months of
cART. The CD4% increased from a mean of 16.5% at
the start to 31.9% at 18 months.
Conclusions
This study from a township in Kwazulu-Natal shows a
good clinical, immunological and virological response to
cART in HIV-infected infants, despite high baseline viral
loads and advanced disease.
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